Understand the source comparison
Best Peptides for Acid Reflux: Research Compound Comparison
BPC-157 Angiogenesis promotion, VEGF activation, mucosal repair 72% ulcer area reduction in 7 days (rat models); complete healing in 68% by day 14 Intraperitoneal, subcutaneous; oral bioavailability uncharacterised Gastric ulcer healing, NSAID-induced damage,
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Angiogenesis promotion, VEGF activation, mucosal repair
- 72% ulcer area reduction in 7 days (rat models); complete healing in 68% by day 14
- Intraperitoneal, subcutaneous; oral bioavailability uncharacterised
- Gastric ulcer healing, NSAID-induced damage, cytoprotective pathways
- Most robust preclinical healing data; lacks human trials; useful mechanistic probe for repair cascades
- KPV
- NF-κB inhibition, cytokine suppression (TNF-alpha, IL-6, IL-1beta)
- 47% TNF-alpha reduction, 52% histological damage reduction in colitis models
- Subcutaneous, sublingual; oral bioavailability <5%
- Inflammatory pathway dissection, combination with acid suppressants
- Potent anti-inflammatory activity; delivery route limits therapeutic translation; strong research tool
- Thymalin
- T-cell modulation, regulatory immune response enhancement, barrier integrity
- 58% lesion reduction in stress ulcer models; 41% mucus layer increase
- Intramuscular; peptide extract stability variable
- Immune-epithelial crosstalk, barrier function under chronic inflammation
- Addresses immune component of reflux; limited gastric-specific trials; promising for chronic pathology models